|
|
|
|
CME Program Alert: Perspectives in the Treatment of Ulcerative Colitis for the Community-Based Gastroenterologist
SOURCE: CECity.com, Inc.
2:22PM, April 20, 2006
Homestead, PA 04/20/2006 — The University of Chicago Pritzker School of Medicine is pleased to announce the launch of a new CME activity entitled Perspectives in the Treatment of Ulcerative Colitis for the Community-Based Gastroenterologist. This activity is made possible by an unrestricted educational grant from Centocor, Inc.
Available online at http://www.cemedicus.com/uccme, the program informs participants about the most current data on the diagnosis and treatment of ulcerative colitis, focusing on emerging treatment options. Clinicians will be updated on recent clinical trial results, and will have an opportunity to compare and contrast conventional and emerging medical and surgical treatment options. Gastroenterologists and other healthcare professionals involved in the management of ulcerative colitis are invited to participate in the free program led by Program Co-Chairs, Stephen Hanauer, MD, Professor of Medicine and Clinical Pharmacology and the Director, Section of Gastroenterology and Nutrition, University of Chicago, Chicago, Illinois; and William J. Sandborn, MD, Professor of Medicine, Division of Gastroenterology and Internal Medicine and Head, IBD Interest Group and Clinical Research Unit, Mayo Clinic, Rochester, Minnesota.
At the conclusion of this continuing medical education activity, the participant should be able to: describe the typical disease course in a patient with ulcerative colitis, compare and contrast currently available pharmacologic options for ulcerative colitis, describe post surgical complications associated with the surgical treatment of ulcerative colitis and the subsequent management, and discuss recent clinical trials of emerging pharmacological treatment options for ulcerative colitis and identify strengths, limitations and implications for future treatments for this disease.
Accreditation and Credit Designation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through The University of Chicago Pritzker School of Medicine. The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Chicago Pritzker School of Medicine designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Declaration
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g. their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery system.
Unlabeled Use Disclosure
This educational activity will not contain discussion of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.
CE Medicus® is powered by and is a Registered Service mark of CECity.com, Inc®.
For additional information visit
www.cemedicus.com/uccme
|
|
|
|
|
|
We subscribe to the HONcode principles of the Health On the Net Foundation